TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Recipharm AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
622,493
|
714,735
|
563,230 |
| Financial expenses |
1,064,959
|
6,615,094
|
3,242,919 |
| Earnings before taxes |
5,483,216
|
-8,924,910
|
-19,946 |
| EBITDA |
-293,598
|
-310,489
|
-166,861 |
| Total assets |
20,918,827
|
23,246,205
|
27,913,303 |
| Current assets |
8,030,107
|
13,186,643
|
3,759,869 |
| Current liabilities |
2,530,715
|
4,456,780
|
2,000,099 |
| Equity capital |
8,076,707
|
9,282,627
|
17,011,576 |
| - share capital |
52,140
|
51,217
|
47,823 |
| Employees (average) |
44
|
60
|
67 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.6%
|
39.9%
|
60.9% |
| Turnover per employee |
14,148
|
11,912
|
8,406 |
| Profit as a percentage of turnover |
880.8%
|
-1248.7%
|
-3.5% |
| Return on assets (ROA) |
31.3%
|
-9.9%
|
11.5% |
| Current ratio |
317.3%
|
295.9%
|
188.0% |
| Return on equity (ROE) |
67.9%
|
-96.1%
|
-0.1% |
| Change turnover |
-105,129
|
111,540
|
328,763 |
| Change turnover % |
-14%
|
18%
|
140% |
| Chg. No. of employees |
-16
|
-7
|
3 |
| Chg. No. of employees % |
-27%
|
-10%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.